Boai NKY Pharmaceuticals was the first domestic company to develop and manufacture polyvinylpyrrolidone (PVP) series products in China. With more than 27 year’s experience in PVP production coupled to a dedicated commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP’s and third largest globally.

• Publicly traded company on the Shenzhen stock exchange
• First domestic company to develop and manufacture PVP and PVM/MA products
• 3rd Largest Global PVP manufacturer
• 2nd Largest Global PVM/MA manufacturer
• International subsidiaries in China,Europe and Japan
• Global distribution network

Products

• KoVidone® and PolyKoVidone® line of products representing Povidone, Crospovidone and Copovidone pharmaceutical excipients.
• OraRez® line of PVM/MA copolymer and derivatives representing functional polymers for bioadhesive/mucoadhesive applications.
• KoVidone®-I (PVP-I) broad spectrum biocidal, antifungal and antiviral agent.
• Pharmaceutical solvents and intermediates.

 Quality

• First Chinese manufacturer to be EXCiPACTTM GMP certified
• All pharmaceutical products manufactured under strict cGMP guidelines
• All pharma products handled and packaged in class D cleanrooms
• State of the art manufacturing facility (commissioned 2013)
• QC equipment and test methods fully validated and fully audit trail compliant

Environmental Responsibility

• Fully compliant with government requirements and regulations
• Real time monitoring of waste streams
• 100% recycling of processing water
• Complete conversion from coal to natural gas
• Focus on developing green production processes

Customer and Technical Service

• Technical Research Center to assist our customer with formulation development
• New R&D center commissioned in 2018 having integrated R&D and pilot manufacturin
• Customer partnering to develop new opportunities
• Strong customer and quality management services to assist our customers